![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print March 4, 2008
J. Biol. Chem, 10.1074/jbc.M800460200
Submitted on January 17, 2008
Revised on February 28, 2008
Accepted on March 4, 2008
Graduate Center for Toxicology, University of Kentucky, Lexington, KY 40536
Corresponding Author: gmli{at}uky.edu
This report describes the identification and purification of a novel mismatch repair stimulatory factor from HeLa cell extracts. This activity copurifies with a PCNA-dependent 5'3' DNA excision activity during several purification steps, but is resolved from the excision activity during gel filtration chromatography using Sephacryl S-300. After purification to near homogeneity, the stimulatory factor is associated with three polypeptides with apparent molecular masses of 68, 36, and 30 kDa. Peptide sequencing analysis by tandem mass spectrometry identified the stimulatory factor as the heterotrimeric regulatory factor X (RFX) complex, which regulates transcription of the class II major histocompatibility complex by facilitating histone acetylation and is defective in the human hereditary immunodeficiency syndrome called Bare Lymphocyte Syndrome. This conclusion was confirmed by the fact that purified recombinant RFX stimulates mismatch repair in an in vitro reconstituted mismatch repair system, and that depletion of RFX from nuclear extracts or RFX knockdown in cells reduces mismatch repair activity. As expected, RFX knockdown cells display instability in microsatellite sequences. The possible role of RFX in human MMR repair is discussed.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |